Form 4 for NOC Northrop Grumman
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001628280-25-006864 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-20 | 2025-02-18 | NOC | Simpson Kathryn G | GC, Corp VP | M - OptEx | $0.00 | +1,565 | 2,764 | +130% | $0 |
| D | 2025-02-20 | 2025-02-18 | NOC | Simpson Kathryn G | GC, Corp VP | S - Sale+OE | $445.35 | -889 | 1,814 | -33% | -$395.9K |
| DM | 2025-02-20 | 2025-02-18 | NOC | Simpson Kathryn G | GC, Corp VP | F - Tax | $441.36 | -529 | 2,398 | -18% | -$233.5K |
| DM | 2025-02-20 | 2025-02-18 | NOC | Simpson Kathryn G | GC, Corp VP | A - Grant | $0.00 | +6,321 | 4,552 | New | $0 |
| DM | 2025-02-20 | 2025-02-18 | NOC | Simpson Kathryn G | GC, Corp VP | M - OptEx | $0.00 | -1,565 | 4,084 | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | M | A | 468 | $0.00 | 2,866.43 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-18 | S | D | 889 | $445.35 | 1,814.43 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2024. |
| 3 | Common | Common Stock | 2025-02-18 | F | D | 163 | $441.36 | 2,703.43 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-18 | F | D | 366 | $441.36 | 2,398.43 | D | — | — | |
| 5 | Common | Common Stock | 2025-02-18 | M | A | 1,096.75 | $0.00 | 2,764.43 | D | — | — | |
| 6 | Derivative | Restricted Performance Stock Rights | 2025-02-18 | A | A | 4,355.75 | $0.00 | 10,056.75 | D | — · — to — | 4,355.75 Common Stock | (F3) The RPSRs acquired include (i) 71.75 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 4,284 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 1,096.75 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 1,025 RPSRs was previously reported in connection with the grant of the 2022 RPSRs. (F4) Total amount includes (i) 1,096.75 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 902 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 3,774 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iv) 4,284 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. (F2) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| 7 | Derivative | Restricted Stock Rights | 2025-02-18 | A | A | 1,965 | $0.00 | 4,552 | D | — · — to — | 1,965 Common Stock | (F7) Total amount includes (i) 468 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 387 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 1,732 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; and (iv) 1,965 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28. (F5) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock (F6) The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028. |
| 8 | Derivative | Restricted Performance Stock Rights | 2025-02-18 | M | D | 1,096.75 | $0.00 | 8,960 | D | — · — to — | 1,096.75 Common Stock | (F8) Total amount includes (i) 902 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 3,774 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iii) 4,284 RPSRs granted under the 2024 LITSP on 2/15/25 with a measurement period ending on 12/31/27. (F2) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| 9 | Derivative | Restricted Stock Rights | 2025-02-18 | M | D | 468 | $0.00 | 4,084 | D | — · — to — | 468 Common Stock | (F5) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock (F9) Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25. |